We identified SIRT3 as the direct target of CVB-D and elucidated the precise mechanism by which CVB-D acts on the SIRT3-ATP5O axis to alleviate DCM pathology, restore mitochondrial morphology, and mitigate senescence in DCM mice. The gene discussed is SIRT3; the disease is familial dilated cardiomyopathy.